Literature DB >> 20970412

Biological reactive intermediates (BRIs) formed from botanical dietary supplements.

Birgit M Dietz1, Judy L Bolton.   

Abstract

The use of botanical dietary supplements is increasingly popular, due to their natural origin and the perceived assumption that they are safer than prescription drugs. While most botanical dietary supplements can be considered safe, a few contain compounds, which can be converted to biological reactive intermediates (BRIs) causing toxicity. For example, sassafras oil contains safrole, which can be converted to a reactive carbocation forming genotoxic DNA adducts. Alternatively, some botanical dietary supplements contain stable BRIs such as simple Michael acceptors that react with chemosensor proteins such as Keap1 resulting in induction of protective detoxification enzymes. Examples include curcumin from turmeric, xanthohumol from hops, and Z-ligustilide from dang gui. Quinones (sassafras, kava, black cohosh), quinone methides (sassafras), and epoxides (pennyroyal oil) represent BRIs of intermediate reactivity, which could generate both genotoxic and/or chemopreventive effects. The biological targets of BRIs formed from botanical dietary supplements and their resulting toxic and/or chemopreventive effects are closely linked to the reactivity of BRIs as well as dose and time of exposure.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20970412      PMCID: PMC3706091          DOI: 10.1016/j.cbi.2010.10.007

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  90 in total

1.  Alternative medicine. Herbal product linked to cancer.

Authors:  L Greensfelder
Journal:  Science       Date:  2000-06-16       Impact factor: 47.728

Review 2.  Clinically based evidence of drug-herb interactions: a systematic review.

Authors:  Deborah A Kennedy; Dugald Seely
Journal:  Expert Opin Drug Saf       Date:  2010-01       Impact factor: 4.250

3.  Metabolism of (R)-(+)-pulegone in F344 rats.

Authors:  L J Chen; E H Lebetkin; L T Burka
Journal:  Drug Metab Dispos       Date:  2001-12       Impact factor: 3.922

Review 4.  Flavonoids and alkenylbenzenes: mechanisms of mutagenic action and carcinogenic risk.

Authors:  Ivonne M C M Rietjens; Marelle G Boersma; Hester van der Woude; Suzanne M F Jeurissen; Maaike E Schutte; Gerrit M Alink
Journal:  Mutat Res       Date:  2005-03-31       Impact factor: 2.433

5.  Biological inhibitory effects of the Chinese herb danggui on brain astrocytoma.

Authors:  Wei-Hwa Lee; Jong-Shiaw Jin; Wen-Chiuan Tsai; Yu-Ting Chen; Wen-Liang Chang; Chen-Wen Yao; Lia-Fa Sheu; Ann Chen
Journal:  Pathobiology       Date:  2006       Impact factor: 4.342

6.  Antigenotoxic effect of Xanthohumol in rat liver slices.

Authors:  Janja Plazar; Metka Filipic; Geny M M Groothuis
Journal:  Toxicol In Vitro       Date:  2007-09-25       Impact factor: 3.500

7.  Composition and biological activity of traditional and commercial kava extracts.

Authors:  Cynthia S Côté; Christine Kor; Jon Cohen; Karine Auclair
Journal:  Biochem Biophys Res Commun       Date:  2004-09-10       Impact factor: 3.575

8.  Pulegone mediated hepatotoxicity: evidence for covalent binding of R(+)-[14C]pulegone to microsomal proteins in vitro.

Authors:  K M Madyastha; B Moorthy
Journal:  Chem Biol Interact       Date:  1989       Impact factor: 5.192

Review 9.  Pennyroyal toxicity: measurement of toxic metabolite levels in two cases and review of the literature.

Authors:  I B Anderson; W H Mullen; J E Meeker; S Oishi; S D Nelson; P D Blanc
Journal:  Ann Intern Med       Date:  1996-04-15       Impact factor: 25.391

10.  Evidence that 4-allyl-o-quinones spontaneously rearrange to their more electrophilic quinone methides: potential bioactivation mechanism for the hepatocarcinogen safrole.

Authors:  J L Bolton; N M Acay; V Vukomanovic
Journal:  Chem Res Toxicol       Date:  1994 May-Jun       Impact factor: 3.739

View more
  7 in total

1.  The anti-inflammatory activity of curcumin is mediated by its oxidative metabolites.

Authors:  Rebecca L Edwards; Paula B Luis; Paolo V Varuzza; Akil I Joseph; Sai Han Presley; Rupesh Chaturvedi; Claus Schneider
Journal:  J Biol Chem       Date:  2017-11-02       Impact factor: 5.157

2.  Pharmacodynamics of ginsenosides: antioxidant activities, activation of Nrf2, and potential synergistic effects of combinations.

Authors:  Constance Lay Lay Saw; Anne Yuqing Yang; David C Cheng; Sarandeep S-S Boyanapalli; Zheng-Yuan Su; Tin Oo Khor; Song Gao; Jingrong Wang; Zhi-Hong Jiang; Ah-Ng Tony Kong
Journal:  Chem Res Toxicol       Date:  2012-08-09       Impact factor: 3.739

3.  The Prenylflavonoid Xanthohumol Reduces Alzheimer-Like Changes and Modulates Multiple Pathogenic Molecular Pathways in the Neuro2a/APPswe Cell Model of AD.

Authors:  Xianfeng Huang; Jing Wang; Xiao Chen; Pan Liu; Shujin Wang; Fangchen Song; Zaijun Zhang; Feiqi Zhu; Xinfeng Huang; Jianjun Liu; Guoqiang Song; Peter S Spencer; Xifei Yang
Journal:  Front Pharmacol       Date:  2018-04-04       Impact factor: 5.810

Review 4.  Usage, biological activity, and safety of selected botanical dietary supplements consumed in the United States.

Authors:  P Annécie Benatrehina; Li Pan; C Benjamin Naman; Jie Li; A Douglas Kinghorn
Journal:  J Tradit Complement Med       Date:  2018-03-02

Review 5.  Myristicin and Elemicin: Potentially Toxic Alkenylbenzenes in Food.

Authors:  Mario E Götz; Benjamin Sachse; Bernd Schäfer; Andreas Eisenreich
Journal:  Foods       Date:  2022-07-05

6.  Evaluation of estrogenic activity of licorice species in comparison with hops used in botanicals for menopausal symptoms.

Authors:  Atieh Hajirahimkhan; Charlotte Simmler; Yang Yuan; Jeffrey R Anderson; Shao-Nong Chen; Dejan Nikolić; Birgit M Dietz; Guido F Pauli; Richard B van Breemen; Judy L Bolton
Journal:  PLoS One       Date:  2013-07-12       Impact factor: 3.240

Review 7.  The Enigma of Bioactivity and Toxicity of Botanical Oils for Skin Care.

Authors:  Erin M Moore; Charles Wagner; Slavko Komarnytsky
Journal:  Front Pharmacol       Date:  2020-05-29       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.